[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Zoetis Inc Cl A (ZTS)

Zoetis Inc Cl A (ZTS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Zoetis Earnings Preview: What to Expect

With a market cap of $31.2 billion, Zoetis Inc. (ZTS) is the world's leading animal health company, dedicated to advancing animal care through innovative medicines, vaccines, diagnostics, biopharmaceuticals, and digital solutions. With nearly 75 years of scientific expertise and a presence in over 100 countries, Zoetis empowers veterinarians, livestock producers, and pet owners by pioneering solutions to predict, prevent, detect, and treat animal illness.

The Parsippany, New Jersey-based company is slated to announce its fiscal Q2 2026 results before the market opens on Thursday, Aug. 6. Ahead of the event, analysts expect Zoetis to report an adjusted EPS of $1.85, up 5.1% from ...

Fundamentals

See More
  • Market Capitalization, $K 32,242,828
  • Shares Outstanding, K 419,228
  • Annual Sales, $ 9,467 M
  • Annual Income, $ 2,673 M
  • EBIT $ 3,435 M
  • EBITDA $ 3,922 M
  • 60-Month Beta 0.75
  • Price/Sales 3.30
  • Price/Cash Flow 9.85
  • Price/Book 9.70

Options Overview Details

View History
  • Implied Volatility 49.13% (+1.46%)
  • Historical Volatility 30.74%
  • IV Percentile 99%
  • IV Rank 99.67%
  • IV High 49.22% on 07/14/26
  • IV Low 22.52% on 08/12/25
  • Expected Move (DTE 34) 7.65 (9.99%)
  • Put/Call Vol Ratio 0.67
  • Today's Volume 3,371
  • Volume Avg (30-Day) 4,526
  • Put/Call OI Ratio 0.59
  • Today's Open Interest 160,978
  • Open Int (30-Day) 147,199
  • Expected Range 68.91 to 84.21

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $1.85
  • Number of Estimates 8
  • High Estimate $1.89
  • Low Estimate $1.77
  • Prior Year $1.76
  • Growth Rate Est. (year over year) +5.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
71.47 +7.12%
on 06/30/26
79.90 -4.19%
on 06/25/26
-0.70 (-0.91%)
since 06/17/26
3-Month
71.47 +7.12%
on 06/30/26
123.32 -37.92%
on 04/20/26
-45.82 (-37.44%)
since 04/17/26
52-Week
71.47 +7.12%
on 06/30/26
160.48 -52.29%
on 08/20/25
-73.47 (-48.97%)
since 07/17/25

Most Recent Stories

More News
Zoetis Inc. (ZTS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ZOETIS INC. (ZTS), CLICK HERE   BEFORE JULY 27, 2026 (THE LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD ...

ZTS : 76.56 (-0.46%)
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of July 27, 2026 in Zoetis Inc. Lawsuit - ZTS

Wall Street's Reassessment of Zoetis Accelerated as Analyst Downgrades Followed Each Corrective Disclosure, Reflecting Growing Skepticism That Management's Companion Animal Growth Narrative Was Built on...

ZTS : 76.56 (-0.46%)
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zoetis Inc. of Class Action Lawsuit and Upcoming Deadlines - ZTS

NEW YORK , July 16, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Zoetis Inc. ("Zoetis" or the "Company") (NYSE: ZTS).   Such investors are...

ZTS : 76.56 (-0.46%)
Zoetis Earnings Preview: What to Expect

Zoetis is set to post its second-quarter results next month, and analysts project a single-digit earnings rise.

ABT : 100.68 (+1.87%)
XLV : 161.09 (-0.44%)
$SPX : 7,457.69 (-1.01%)
ZTS : 76.56 (-0.46%)
Zoetis Deadline: ZTS Investors Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit

NEW YORK , July 15, 2026 /PRNewswire/ --

ZTS : 76.56 (-0.46%)
Zoetis Inc. (ZTS) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit - Contact KTMC

Did you buy ZTS securities between January 14, 2025, and May 6, 2026?

ZTS : 76.56 (-0.46%)
Levi & Korsinsky Reminds Zoetis Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of July 27, 2026 - ZTS

Notice to Pension Funds, Asset Managers, and Fiduciaries: Zoetis' Companion Animal Segment Collapse Allegedly Cost Institutional Portfolios Hundreds of Millions

ZTS : 76.56 (-0.46%)
Zoetis Launches Lenivia® (izenivetmab injection) in Canada and the European Union

Up to 40% of dogs may have radiographic osteoarthritis - New long-acting monoclonal antibody therapy offers three months of osteoarthritis pain relief for dogs with a single injection

ZTS : 76.56 (-0.46%)
Kaplan Fox & Kilsheimer LLP Alerts Zoetis Inc. (NYSE: ZTS) Investors to a Securities Class Action Deadline on July 27, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

ZTS : 76.56 (-0.46%)
ZTS Shareholder Alert: Zoetis Inc. Securities Class Action Lawsuit - Investors Should Contact The Gross Law Firm

NEW YORK , July 14, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Zoetis Inc. (NYSE: ZTS).

ZTS : 76.56 (-0.46%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified...

See More

Key Turning Points

3rd Resistance Point 80.22
2nd Resistance Point 79.13
1st Resistance Point 77.85
Last Price 76.56
1st Support Level 75.48
2nd Support Level 74.39
3rd Support Level 73.11

See More

52-Week High 160.48
Fibonacci 61.8% 126.48
Fibonacci 50% 115.97
Fibonacci 38.2% 105.47
Last Price 76.56
52-Week Low 71.47

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.